TG Therapeutics, Inc.
TGTXNext catalyst
Ublituximab
Non-Hodgkins Lymphoma
Get an email about TGTX's next catalysts
Track TG Therapeutics (TGTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
Plus 1 more upcoming event in our data (Phase 2 readout).See the timeline
2 upcoming, 3 past
Ublituximab Phase 3 Est. Readout (ENHANCE)
Primary completion for Ublituximab trial (NCT07211633) in Relapsing Multiple Sclerosis
SourceUblituximab Phase 2 Est. Readout
Estimated primary completion for Ublituximab trial (NCT07503873) in Multiple Sclerosis. Topline data typically follows completion by weeks to months.
SourceHow TGTX's past catalysts played out
Market Overview
Stock performance and key metrics
Teriflunomide
Relapsing Multiple Sclerosis (RMS)
Ublituximab
Non-Hodgkins Lymphoma
Umbralisib
Marginal Zone Lymphoma
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Teriflunomide | Phase 3 | Relapsing Multiple Sclerosis (RMS) | - | - |
Ublituximab | Phase 3 | Non-Hodgkins Lymphoma | - | - |
Umbralisib | Phase 2 | Marginal Zone Lymphoma | - | - |
Relapsing Multiple Sclerosis (RMS)
2 drugs in this indication
Marginal Zone Lymphoma
1 drug in this indication
Non-Hodgkins Lymphoma
1 drug in this indication
Relapsing Multiple Sclerosis
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in TG Therapeutics, Inc.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in TG Therapeutics, Inc.'s (TGTX) pipeline across Phase 3, Phase 2. Its lead program is Ublituximab (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is TG Therapeutics, Inc.'s next FDA catalyst?β
TG Therapeutics, Inc.'s (TGTX) next tracked catalyst is a Phase 3 readout expected January 2027. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TGTX biotech catalysts?β
Add TGTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow TG Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
